How mRNA Vaccines Work and Where Vaccine Science Is Heading Next

Vaccines work by giving the immune system a preview of danger — for instance, a weakened or inactivated version or an isolated piece of a pathogen such as a virus or bacterium. A good vaccine focuses the immune system on parts of a pathogen that are essential to its function, hard for the pathogen to alter without crippling itself, and within easy reach of the immune system.

When a person is vaccinated or infected, it is the adaptive immune system — made of B cells and T cells — that is being trained. Some special B cells are destined to become antibody factories. Antibodies are Y-shaped proteins that protect the body by sticking to pathogens, flagging them for destruction by other parts of the immune system and coating them to prevent infection of cells. Because antibodies float around outside cells while many pathogens, such as viruses, sneak into cells and multiply, T cells play a complementary role. Every cell in the body presents small fragments of its protein molecules on its surface, and the T cell's job is to inspect these fragments. T cells are selected to react only to fragments that are foreign, so when one recognizes a fragment, it either kills the infected cell directly or releases signals to engage a broader immune response.

How the Immune System Learns

Almost every B cell and T cell in the body has a unique receptor — a pathogen detector. When exposed to a pathogen, the body must wait for the right B and T cells to physically encounter it, relying in the meantime on the "innate" immune system to contain the threat. Crucially, when the right B cells and T cells are eventually activated, they make copies of themselves, so that a future encounter with the same pathogen meets many more ready-to-respond cells and pre-existing protective antibodies.

B cells do more than make copies — they learn. Pieces of the pathogen are trafficked to secondary lymphatic organs such as lymph nodes, where small structures called Germinal Centers form. Within each Germinal Center, B cells make new versions of themselves with mutations in their receptors, undergoing accelerated Darwinian evolution to improve their binding to the pathogen. This is how the immune system learns, and vaccination is fundamentally about triggering and steering this learning process.

The mRNA Advantage

One major recent development is mRNA-based vaccines. Traditional vaccines deliver the pathogen itself — weakened or in fragments — whereas mRNA vaccines deliver instructions. mRNA, a DNA-like molecule, encodes the pathogen's telltale parts, and the body's own cellular machinery reads the mRNA and builds those parts. The key advantage is speed: because mRNA is written in a standard molecular language, it is far faster to engineer and synthesize than a weakened, safe version of the pathogen. As a result, mRNA vaccines can be developed and updated in a fraction of the time.

During the COVID pandemic, this speed proved vital. One estimate suggests the COVID vaccine prevented three million American deaths through 2022. This success was not magic — it required decades of exploratory fundamental research, much of it government funded. The benefits are still arriving, as the FDA has now approved mRNA vaccines for the seasonal flu.

What Lies Ahead

Vaccines have traditionally been used for protection against external threats such as flu, measles, or COVID. Now, however, vaccines are also being developed against internal threats, including cancer (搜索)搜索该疾病. In that setting, the target is not an invader from outside but mutations that make cancer cells look foreign. Even within the world of pathogens, certain threats such as HIV (搜索)搜索该疾病 and malaria (搜索)搜索该疾病 remain elusive. Physicists can help meet these challenges by borrowing approaches developed for other complex systems, such as networks, disordered materials, and evolving populations. As researchers continue to decode how the immune system learns, solutions are expected to follow.